Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.
AUTOR(ES)
Ramselaar, A C
RESUMO
A 68 year old man with rheumatoid arthritis developed marrow aplasia during D-penicillamine treatment. Recovery of granulopoiesis and erythropoiesis was ineffective with features of a secondary sideroblastic anaemia. Absence of megakaryopoiesis persisted. Therapeutic measures failed, and the patient finally died. These events illustrate a haematopoietic stem cell injury induced by D-penicillamine.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1002083Documentos Relacionados
- Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.
- Acquired sideroblastic anaemia associated with penicillamine therapy for rheumatoid arthritis.
- D-penicillamine withdrawal in rheumatoid arthritis.
- Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis.
- Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
